Hepatitis. A review of the disease and its significance to dentistry

Prevalence of Hepatitis B surface antigen in dental personnel

Context:

Hepatitis B, a viral disease affecting the liver has high morbidity and mortality. Hepatitis B surface antigen (HBsAg) in serum is used to detect presence of active disease and chronic carrier status. The disease is transmitted predominantly through blood and saliva, hence dental professionals are considered a high risk group.

Aim:

To detect presence of HBsAg in serum of dental professionals.

Subjects and Methods:

The study was conducted in two parts viz., one in the year 1991 on 100 dental professionals in Nagpur using reverse passive hemagglutination and the other in 2012 on 50 dental professionals in Chennai using immunochromatography.

Results:

Ten percent of dental professionals screened in 1991 and 2% of dental professionals screened in 2012 showed HBsAg positive status and were predominantly periodontists with a history of needle-stick injury.

Conclusion:

This study highlights the importance of Hepatitis B vaccination and periodic evaluation of antibody titer to prevent spread of the disease.

The prevalence of hepatitis B virus markers in dental personnel in Singapore

A seroepidemiological survey of the prevalence of hepatitis B virus (HBV) markers was conducted in a group of 693 dental personnel in Singapore where HBV infection is endemic. The overall prevalence of HBsAg (4.5%) and anti-HBc (29%) was no higher than that in the general population. However, dentists had a significantly higher HBsAg prevalence (11.4%) compared with that in the general population (4.2%) (P less than 0.01) and of other categories of dental personnel (3.1%) (P less than 0.001). Similarly, the anti-HBc prevalence of the dentists (45.6%) was significantly higher than that of the general population (29.7%) (P less than 0.01) and of other categories of dental personnel (25.7%) (P less than 0.0001). It appears that dentists in the endemic area have a definite occupational risk of acquiring HBV infection.

Acceptance of hepatitis B vaccine by Rhode Island dental practitioners

A questionnaire survey of 575 dentists practicing in Rhode Island in March 1983 disclosed minimal acceptance of the hepatitis B vaccine. A total of 162 practicing dentists returned the questionnaire; only 23 general practitioners and nine specialists had received the first of the three required doses of the vaccine. The most frequently stated reasons for not receiving the vaccine were that the dentists were concerned about potential long-term side effects, including AIDS and Guillain-Barre syndrome, and wanted further information about the vaccine. It appears that a more intensive professional education program is needed if dental practitioners are to accept hepatitis B vaccine.